Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

4 scenarios that would dramatically improve health care

Robert Pearl, MD
Policy
January 14, 2014
Share
Tweet
Share

Radical change often happens suddenly, the result of a single decision or event.

The fall of the Berlin Wall and the dissolution of the USSR stand out as two dramatic political examples. In a social context, Supreme Court decisions in Brown v. Board of Education or Roe v. Wade both radically changed our society.

Then there’s the U.S. health care system. We know it can take 17 years for a new, proven treatment to make its way into routine patient care. But on occasion, the pace accelerates and the industry is taken by storm. The passage of Medicare in 1965 and, more recently, the Affordable Care Act (ACA) in 2010 are two powerful examples. In both cases, the underlying coverage issues were debated for decades. But with their legislative passage, each brought sudden and unprecedented change to U.S. health care.

As we begin the New Year, I invite you to indulge in a thought exercise: Imagine what would happen to our health care system if the following hypothetical scenarios suddenly became reality.

Hypothetical #1: Legal access to medications beyond U.S. borders

What if U.S. patients could purchase prescription drugs from pharmacies in other effectively regulated countries?

When it comes to automobiles, new technologies or retail products, we do not hesitate to take advantage of price differences beyond our borders. Why not allow such an approach for pharmaceutical agents?

Does anyone really believe that brand-name prescription drugs sold at significantly discounted prices across our northern border — or in countries like England or Switzerland — are inferior to the exact same brands provided by pharmacies in the U.S.? Big pharma, also known as the U.S. drug lobby, wields massive political power. They are the reason this practice is prohibited.

Were this hypothetical to become a reality, we could expect U.S. drug companies to reduce their supply to those nations that would sell to Americans at lower prices. The U.S. government could counter this move with reference pricing regulations. In other words, public payers would only reimburse the price offered overseas for any given medication. Patients would be required to pick up the rest.

We have seen this in other areas of health care. The Pacific Business Group on Health (PBGH) limited what it would pay for hip replacements. Hospitals subsequently dropped the price of the procedure. With medications, market forces would likely drive down prices and put the U.S. at par with the rest of the world. This hypothetical raises an important question: How much longer do we want U.S. patients to pay more than the rest of the world for the exact same medications?

Hypothetical #2: Raising the regulatory bar for new devices and drugs

What if all new medical devices and drugs that target a specific condition had to be tested against those currently on the market? And what if they couldn’t be sold at a premium if their outcomes didn’t prove significantly better?

Once a new drug is proven relatively safe, the bar for regulatory approval by the Food and Drug Administration (FDA) is low. Manufacturers only are required to test new medications against placebo, not against similar medications currently on the market. If every new medication or device had to be tested against the best available alternative, then patients — not manufacturers — could decide whether the difference in outcome was worth the dramatically higher price.

Patients deserve this information. Without it, aggressive advertising, persistent drug reps and guaranteed long-term patent protection enable new pills to be sold at extremely high prices without letting anyone to be sure they’re worth it.

Device manufacturers enjoy similar opportunities and advantages. In addition, they can forgo the standard approval pathway by seeking it through the Premarket Notification or 510(k) clearance. Per the 510(k) clearance, new devices are expeditiously approved if deemed “equivalent” to an existing device on the market. Of course, once the device hits the market, the company’s sales force will claim the new product is unique and therefore warrants its much higher price.

ADVERTISEMENT

By raising the regulatory approval bar, regulators could better protect the health (and life savings) of U.S. patients. But the strength of drug and device manufacturer lobbies has blocked these requirements, so far.

Hypothetical #3: New accreditation standards to improve surgical outcomes 

What if the Joint Commission for Accreditation of Health Care Organizations (JCAHO) refused to accredit facilities with low surgical volumes and thereby improved the quality of outcomes while lowering costs?

More surgical experience produces higher quality outcomes for patients undergoing complex procedures. The reason is simple: higher volumes allow surgical teams to become more specialized in the procedures they do and more comfortable working together.

Higher-volume facilities don’t just produce higher quality outcomes, they produce economies of scale. When volume is low, there’s high variation in daily demand. Some days are busy, others very slow. Nevertheless, the medical staff at low-volume facilities is paid even when service is idle.

Centralizing patient volume would reduce the daily variation, making daily demand more predictable. It would also lower the total cost of surgery for patients. Manufacturers across the world embrace this basic and fundamental economic principle. Why not doctors and hospitals?

Hypothetical #4: Routine use of mobile and video technology

What if insurance companies refused to pay health care providers more for an in-person office visit than a video visit when the medical problem could be addressed equally well in either fashion?

Telemedicine, the use of video technology, has the potential to make medical care more convenient by eliminating the need for patients to drive to the doctor’s office. Anyone who has used Skype or FaceTime to speak with a faraway loved one understands how simple this technology can be to use.

Doing so for medical purposes would lower operational costs, and require less capital investment and fewer office staff.

Of course, there are no technological alternatives for those times when patients require a physical exam. And certainly some patients prefer to be seen in person. But that’s not what’s stopping “virtual visits” from becoming standard practice. The reimbursement system is.

Most insurers pay physicians to see patients only in their offices. And doctors prefer this approach. It doesn’t matter that virtual care could be provided twice as conveniently at half the price.

If we look to other industries, we can predict that most patients would embrace the convenience of telemedicine if it were available.

Health care delivery is structured around the preferences (and economic incentives) of doctors, not patients. We can expect that once reimbursement guidelines shift, so too will this practice.

Going from hypothetical to reality

Of course, these four hypotheticals are merely “what ifs” for now. None are likely to become realities in 2014.

Legislation around reference-based pricing would require overcoming a lot of inertia. Drug and device lobbies are powerful opponents of new regulations. New medical accreditation standards would require setting minimal volumes that are not yet defined. And getting value from telemedicine would necessitate tough standards to avoid doctors creating virtual visits without value.

We shouldn’t underestimate the inherent challenges and resistance in trying to implement major change. But all of these hypotheticals are possible with the right amount of financial incentive and political will.

Besides, ask yourself: If these four hypotheticals became our reality, would we miss the way things are today?

Robert Pearl is a physician and CEO, The Permanente Medical Group. This article originally appeared on Forbes.com.

Prev

A patient trapped in his own body

January 14, 2014 Kevin 21
…
Next

Milestones of children with developmental disabilities should be celebrated

January 14, 2014 Kevin 1
…

Tagged as: Primary Care, Public Health & Policy

Post navigation

< Previous Post
A patient trapped in his own body
Next Post >
Milestones of children with developmental disabilities should be celebrated

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Robert Pearl, MD

  • The emotional toll of a broken health care system

    Robert Pearl, MD
  • Medicare’s cobra effect: How a well-intentioned policy spiraled into a health care crisis

    Robert Pearl, MD
  • Empowering patients: Navigating medical information with AI

    Robert Pearl, MD

More in Policy

  • Why physician voices matter in the fight against anti-LGBTQ+ laws

    BJ Ferguson
  • The silent toll of ICE raids on U.S. patient care

    Carlin Lockwood
  • What Adam Smith would say about America’s for-profit health care

    M. Bennet Broner, PhD
  • The lab behind the lens: Equity begins with diagnosis

    Michael Misialek, MD
  • Conflicts of interest are eroding trust in U.S. health agencies

    Martha Rosenberg
  • When America sneezes, the world catches a cold: Trump’s freeze on HIV/AIDS funding

    Koketso Masenya
  • Most Popular

  • Past Week

    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
    • Physician patriots: the forgotten founders who lit the torch of liberty

      Muhamad Aly Rifai, MD | Physician
    • The hidden cost of becoming a doctor: a South Asian perspective

      Momeina Aslam | Education
    • Why fixing health care’s data quality is crucial for AI success [PODCAST]

      Jay Anders, MD | Podcast
    • Closing the gap in respiratory care: How robotics can expand access in underserved communities

      Evgeny Ignatov, MD, RRT | Tech
    • Reclaiming trust in online health advice [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Recent Posts

    • Why fixing health care’s data quality is crucial for AI success [PODCAST]

      Jay Anders, MD | Podcast
    • Why so many physicians struggle to feel proud—even when they should

      Jessie Mahoney, MD | Physician
    • If I had to choose: Choosing the patient over the protocol

      Patrick Hudson, MD | Physician
    • How a TV drama exposed the hidden grief of doctors

      Lauren Weintraub, MD | Physician
    • Why adults need to rediscover the power of play

      Anthony Fleg, MD | Physician
    • How collaboration across medical disciplines and patient advocacy cured a rare disease [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 3 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
    • Physician patriots: the forgotten founders who lit the torch of liberty

      Muhamad Aly Rifai, MD | Physician
    • The hidden cost of becoming a doctor: a South Asian perspective

      Momeina Aslam | Education
    • Why fixing health care’s data quality is crucial for AI success [PODCAST]

      Jay Anders, MD | Podcast
    • Closing the gap in respiratory care: How robotics can expand access in underserved communities

      Evgeny Ignatov, MD, RRT | Tech
    • Reclaiming trust in online health advice [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Recent Posts

    • Why fixing health care’s data quality is crucial for AI success [PODCAST]

      Jay Anders, MD | Podcast
    • Why so many physicians struggle to feel proud—even when they should

      Jessie Mahoney, MD | Physician
    • If I had to choose: Choosing the patient over the protocol

      Patrick Hudson, MD | Physician
    • How a TV drama exposed the hidden grief of doctors

      Lauren Weintraub, MD | Physician
    • Why adults need to rediscover the power of play

      Anthony Fleg, MD | Physician
    • How collaboration across medical disciplines and patient advocacy cured a rare disease [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

4 scenarios that would dramatically improve health care
3 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...